01:11 PM EDT, 05/23/2024 (MT Newswires) -- Bausch Health's ( BHC ) Canadian unit said Thursday its Uceris aerosol foam treatment for mild to moderate distal ulcerative colitis in adults has become available for patients in other parts of Canada through public drug plans.

The company announced additional public drug plan listings for Uceris in Alberta, Prince Edward Island, and Newfoundland and Labrador. Earlier this year, it was made available for patients through the public drug plans of Ontario, Quebec, Saskatchewan, New Brunswick and Nova Scotia.

Uceris has also become available to beneficiaries of the federal drug plans for Indigenous people through the Non-Insured Health Benefit and Veterans Affairs Canada, the company said.

Price: 6.36, Change: -0.01, Percent Change: -0.24